273 related articles for article (PubMed ID: 27838186)
21. Long-term results of proton beam irradiated uveal melanomas.
Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
[TBL] [Abstract][Full Text] [Related]
22. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
23. Effects on Periocular Tissues after Proton Beam Radiation Therapy for Intraocular Tumors.
Choi YJ; Kim TW; Kim S; Choung H; Lee MJ; Kim N; Khwarg SI; Yu YS
J Korean Med Sci; 2018 Apr; 33(16):e120. PubMed ID: 29651818
[TBL] [Abstract][Full Text] [Related]
24. Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.
Thariat J; Maschi C; Lanteri S; Peyrichon ML; Baillif S; Herault J; Salleron J; Caujolle JP
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):142-151. PubMed ID: 28586953
[TBL] [Abstract][Full Text] [Related]
25. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
[TBL] [Abstract][Full Text] [Related]
26. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
Patel AV; Lane AM; Morrison MA; Trofimov AV; Shih HA; Gragoudas ES; Kim IK
Ophthalmology; 2016 Feb; 123(2):369-377. PubMed ID: 26545316
[TBL] [Abstract][Full Text] [Related]
27. Genetic Risk Factors for Radiation Vasculopathy.
Papakostas TD; Morrison MA; Lane AM; Awh C; DeAngelis MM; Gragoudas ES; Kim IK
Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1547-1553. PubMed ID: 29625478
[TBL] [Abstract][Full Text] [Related]
28. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.
Papakostas TD; Lane AM; Morrison M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2017 Nov; 135(11):1191-1196. PubMed ID: 29049518
[TBL] [Abstract][Full Text] [Related]
29. Retina dose as a predictor for visual acuity loss in
Heilemann G; Fetty L; Blaickner M; Nesvacil N; Zehetmayer M; Georg D; Dunavoelgyi R
Radiother Oncol; 2018 Jun; 127(3):379-384. PubMed ID: 29452902
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
Verma V; Mehta MP
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
[TBL] [Abstract][Full Text] [Related]
31. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K; Naus N; Nowak PJ; Schmitz PI; de Pan C; van Santen CA; Marijnissen JP; Paridaens DA; Levendag PC; Luyten GP
Radiother Oncol; 2012 Feb; 102(2):219-24. PubMed ID: 21864922
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM
Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234
[TBL] [Abstract][Full Text] [Related]
33. [Results of treating uveal melanoma with proton beam radiation: 10-year follow-up].
Hamrouni Z; Levy C; Lumbroso L; D'Hermies F; Frau E; Mazal A; Delacroix S; Nauraye C; Dendale R; Schlienger P; Desjardins L
J Fr Ophtalmol; 2005 Oct; 28(8):833-9. PubMed ID: 16249762
[TBL] [Abstract][Full Text] [Related]
34. 15 years experience with helium ion radiotherapy for uveal melanoma.
Castro JR; Char DH; Petti PL; Daftari IK; Quivey JM; Singh RP; Blakely EA; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):989-96. PubMed ID: 9392536
[TBL] [Abstract][Full Text] [Related]
35. [Endoresection following proton beam irradiation of large uveal melanomas].
Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
[TBL] [Abstract][Full Text] [Related]
36. Plaque brachytherapy for uveal melanoma: a vision prognostication model.
Khan N; Khan MK; Bena J; Macklis R; Singh AD
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e285-90. PubMed ID: 22658514
[TBL] [Abstract][Full Text] [Related]
37. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
38. Ten-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Kroll SM; Castro J
Am J Ophthalmol; 1998 Jan; 125(1):81-9. PubMed ID: 9437317
[TBL] [Abstract][Full Text] [Related]
39. Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma.
Gigliotti CR; Modorati G; Di Nicola M; Fiorino C; Perna LA; Miserocchi E; Franzin A; Picozzi P; Bolognesi A; Mortini P; Del Vecchio A; Calandrino R
Br J Ophthalmol; 2018 Jun; 102(6):833-839. PubMed ID: 28903963
[TBL] [Abstract][Full Text] [Related]
40. Good long-term visual outcomes of parapapillary choroidal melanoma patients treated with proton therapy: a comparative study.
Pica A; Weber DC; Vallat L; Bergin C; Hrbacek J; Schweizer C; Zografos L; Schalenbourg A
Int Ophthalmol; 2021 Feb; 41(2):441-452. PubMed ID: 32975693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
